LifeMD (LFMD) Stock Forecast & Price Target

LifeMD Inc. has demonstrated significant growth in its telehealth segment, with the active subscriber base expanding by 14% year-over-year to reach 310,818 by the end of the third quarter of 2025. In the same period, the company's Telehealth revenue rose by 17.4% to $47.3 million, contributing to a total revenue of $60.2 million, reflecting a 12.7% year-over-year growth despite falling short of projections. The recent introduction of competitive pricing for new products, along with heavy investments in telehealth infrastructure and partnerships, indicates a strong potential for continued revenue growth and market expansion.

LifeMD Inc. reported revenues of $60.2 million for the recent quarter, reflecting a year-over-year growth of 13%, which fell short of the consensus and guidance expectations of up to $62.6 million. The company's adjusted EBITDA of $5.1 million, a 20% increase year-over-year, also did not meet projected figures, indicating challenges in maintaining profitability amid competitive pressures in the telehealth market. Additionally, LifeMD has reduced its full-year 2025 revenue guidance, anticipating $192 million to $193 million from the telehealth segment, as it faces significant risks including slower revenue growth, difficulties in patient acquisition, and heightened competition from lower-cost alternatives.